Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvedBy |
gptkb:European_Union
gptkb:United_States |
| gptkbp:ATCCode |
A16AB23
|
| gptkbp:developer |
gptkb:Chiesi_Farmaceutici
Protalix BioTherapeutics |
| gptkbp:drugClass |
recombinant human alpha-galactosidase A
|
| https://www.w3.org/2000/01/rdf-schema#label |
pegunigalsidase alfa
|
| gptkbp:indication |
treatment of adults with Fabry disease
|
| gptkbp:mechanismOfAction |
enzyme replacement
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:synonym |
Elfabrio
|
| gptkbp:usedFor |
gptkb:Fabry_disease
|
| gptkbp:bfsParent |
gptkb:M09AX16
|
| gptkbp:bfsLayer |
6
|